Reuters logo
BRIEF-Horizon Pharma says first patient enrolled in confirmatory Phase 3 clinical trial evaluating Teprotumumab
2017年10月25日 / 下午3点06分 / 1 个月前

BRIEF-Horizon Pharma says first patient enrolled in confirmatory Phase 3 clinical trial evaluating Teprotumumab

Oct 25 (Reuters) - Horizon Pharma Plc

* Horizon Pharma Plc announces first patient enrolled in confirmatory Phase 3 clinical trial evaluating Teprotumumab for the treatment of moderate-to-severe active thyroid eye disease Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below